Hoxton Planning & Management LLC Has $589,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hoxton Planning & Management LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,156 shares of the healthcare conglomerate’s stock after selling 78 shares during the period. Hoxton Planning & Management LLC’s holdings in UnitedHealth Group were worth $589,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of UNH. Mason & Associates Inc lifted its stake in shares of UnitedHealth Group by 23.0% in the 2nd quarter. Mason & Associates Inc now owns 4,106 shares of the healthcare conglomerate’s stock valued at $2,091,000 after purchasing an additional 768 shares during the last quarter. TCW Group Inc. lifted its stake in shares of UnitedHealth Group by 4.6% in the 2nd quarter. TCW Group Inc. now owns 260,232 shares of the healthcare conglomerate’s stock valued at $132,526,000 after purchasing an additional 11,529 shares during the last quarter. Unique Wealth LLC lifted its stake in shares of UnitedHealth Group by 12.7% in the 2nd quarter. Unique Wealth LLC now owns 3,233 shares of the healthcare conglomerate’s stock valued at $1,641,000 after purchasing an additional 364 shares during the last quarter. Signature Resources Capital Management LLC lifted its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. Finally, CFM Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 19.3% in the 2nd quarter. CFM Wealth Partners LLC now owns 3,399 shares of the healthcare conglomerate’s stock valued at $1,731,000 after purchasing an additional 549 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $1.93 during mid-day trading on Friday, hitting $577.68. 2,728,939 shares of the stock were exchanged, compared to its average volume of 4,224,914. The company has a market cap of $533.44 billion, a P/E ratio of 35.31, a PEG ratio of 1.61 and a beta of 0.59. The stock’s fifty day simple moving average is $529.38 and its two-hundred day simple moving average is $507.45. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $591.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter last year, the business posted $6.14 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. TD Cowen boosted their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. UBS Group boosted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. HSBC boosted their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $614.17.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.